Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Expanded ATXN3 CAG Repeat is Stable in Human Purkinje Cells.

Created on 08 Aug 2026

Authors

Hasnahana Chetia, Laura Kus, Erika Sipos, Nathaniel Heintz, Kert Mätlik

Published in

Movement disorders : official journal of the Movement Disorder Society. Aug 07, 2026. Epub Aug 07, 2026.

Abstract

Spinocerebellar ataxia type 3 (SCA3) is a neurodegenerative disorder caused by an abnormally long polyglutamine-encoding CAG repeat in the ATXN3 gene.
We aimed to determine whether somatic expansion of the mutant ATXN3 (mATXN3) CAG repeat is present in the output cell of the cerebellar cortex, the Purkinje cell (PC), in individuals affected with SCA3.
We combined sorting of cell nuclei from post-mortem brain tissue, transcriptome analysis-based confirmation of sample purity, and high-depth sequencing of ATXN3 exon 10 amplicons to analyze the stability of mATXN3 CAG repeat in PCs in individuals with SCA3.
We demonstrated that the expansion of mATXN3 CAG repeat in PCs is minimal, comparable with cerebellar granule neurons, and the repeat is more stable in PCs compared with striatal medium spiny neurons.
The modest somatic expansion of the mATXN3 CAG repeat observed in PCs is likely not responsible for their loss in individuals with SCA3. © 2026 The Author(s). Movement Disorders published by Wiley Periodicals LLC on behalf of International Parkinson and Movement Disorder Society.

PMID:
42568078
Bibliographic data and abstract were imported from PubMed on 08 Aug 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 1
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement